Adtran stock plunges nearly 16% as Q2 revenue, margin guidance disappoints

Adtran stock plunges nearly 16% as Q2 revenue, margin guidance disappoints
Adtran drops 15.82% today on results

ADTRAN Inc (ADTN) plunged 15.82% after the company released preliminary unaudited second-quarter results well below prior guidance and market expectations. The scale of the drop is reinforced by broad selling pressure, as Adtran remains below all key moving averages and signals for both momentum and oscillators remain negative, with some oversold signs limiting further downside.

ADTN price prediction
24H 0%
$4.83
48H -1.24%
$4.77
7D -0.21%
$4.82
1M -39.34%
$2.93
3M -49.48%
$2.44
6M -25.88%
$3.58
12M -58.8%
$1.99
Current price: $4.83 -0.0300 0.62%
Closed 11/13
Daily range 4.75 Arrow from to Icon 4.95
Weekly range 4.06 Arrow from to Icon 4.95
Loading...

Highlights

  • Adtran's Q2 preliminary revenue of $280–$282 million and non-GAAP operating margin of 3.5–4% both fell short of prior guidance and consensus expectations.
  • The company lowered its revenue outlook for the upcoming quarter and forecast a GAAP EPS loss of $(0.12) to $(0.14) for Q2.
  • Technical signals reflect sustained bearish momentum with the stock trading under key moving averages and an expected near-term price range of $9.78 to $10.91.

Revenue and margin forecasts cut as outlook sours

Adtran Holdings, Inc. announced preliminary unaudited financial results for the second quarter of 2026, projecting revenue between $280 million and $282 million, which falls short of previous guidance and the analyst consensus. The preliminary non-GAAP operating margin is estimated at 3.5% to 4.0%, below the earlier guidance of 5% to 9%. The company also reduced its revenue outlook for the upcoming quarter and anticipates a GAAP basic and diluted loss per common share between $(0.12) and $(0.14), accompanied by a lowered revenue forecast for Q3.

Anton Kharitonov, expert at Traders Union, believes the sharp miss in Adtran’s preliminary financials and the downward revision in guidance point to weakening fundamentals. He notes persistent selling as the stock trades beneath all key moving averages and negative momentum readings dominate. Kharitonov sees little relief from oversold indicators, as oscillators and MACD continue to confirm a sell bias. He is critical of management’s lower operating margin outlook and shrinking revenue guidance. "The technical and fundamental setup reinforces high risk, and any rebound attempts should be viewed with skepticism until there’s tangible improvement in results."
Viktoras Karapetjanc, expert at Traders Union, sees the current volatility as an opportunity for investors. He points out that the long-term bullish structure remains intact, with the 50-day average above the 200-day. The selloff opens attractive entry points, especially as oversold signals accumulate. Karapetjanc is confident the lowered guidance is already priced in, and forward-looking investors can explore setups near support levels. "I expect the market will soon refocus on Adtran’s underlying strengths, and further growth is likely if buyers reclaim the $10.3 mark."
Parshwa Turakhiya, analyst, finds short-term sentiment extremely cautious after Adtran’s gap down. He notes conflicting momentum signals — with MACD and CCI negative but Stochastic RSI turning bullish — as evidence of potential mean reversion setups. Turakhiya highlights elevated volatility and suggests possible sideways trading in the forecasted $9.78 to $10.91 range. "With so many sentiment-driven signals flashing, nimble traders may find quick opportunities once oversold conditions start unwinding."

Persistent seller control as technical signals show mixed exhaustion

Adtran is trading below its 20-day, 50-day, and 200-day moving averages at $12.96, $14.65, and $11.54, respectively, indicating persistent pressure from sellers across all time frames. The near-term ceiling for the stock is set at $10.3, with support observed at $9.78. While the longer-term trend structure remains bullish based on the alignment of the 50-day against the 200-day average, short-term momentum readings are negative. The MACD and RSI both signal a sell bias, the ADX reads neutral, and the CCI is also in sell territory. The BBP value is negative, confirming intraday selling dominance with an oversold outlook. The stock shows oversold conditions on both RSI and CCI, while the Stochastic RSI indicates strong buy conditions. Adtran fell $1.92, opening with a downside gap of about $2.4, and is currently near the high of its intraday range. Intraday volatility stands at 10.04%. This sharp decline, combined with conflicting signals from momentum and oscillators, indicates ongoing pressure but suggests seller exhaustion may be emerging.

Earlier, analysts noted that Adtran was struggling with technical selling pressure and prevailing bearish momentum. The latest fundamental deterioration and persistent oversold signals reinforce the downside risk, making the $9.78 level critical for gauging whether further weakness will unfold in the near term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.